These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 18816632)

  • 21. Human epidermal growth factor receptor 2 expression in breast cancer: correlation with clinical pathological features.
    Ning SF; Li JL; Luo CP; Wei CH; Lu YK; Liu HZ; Wei WE; Zhang LT
    Int J Clin Exp Pathol; 2014; 7(12):8740-7. PubMed ID: 25674240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ESR1 and PIK3CA mutational status in serum and plasma from metastatic breast cancer patients: A comparative study.
    Takeshita T; Yamamoto Y; Yamamoto-Ibusuki M; Tomiguchi M; Sueta A; Iwase H
    Cancer Biomark; 2018; 22(2):345-350. PubMed ID: 29689710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
    Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
    Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen receptor α (ERα) status evaluation using RNAscope in situ hybridization: a reliable and complementary method for IHC in breast cancer tissues.
    Yu X; Guo S; Song W; Xiang T; Yang C; Tao K; Zhou L; Cao Y; Liu S
    Hum Pathol; 2017 Mar; 61():121-129. PubMed ID: 27993577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of erbB-2 oncoprotein in human breast cancers by ELISA.
    Nugent A; McDermott E; O'Higgins N; Fennelly JJ; Duffy MJ
    Biochem Soc Trans; 1992 Feb; 20(1):82S. PubMed ID: 1353039
    [No Abstract]   [Full Text] [Related]  

  • 26. Relationship among prognostic laboratory indices in breast cancers.
    Miller JM; Debari VA; Rubin AD; Todd DM
    J Natl Cancer Inst; 1992 Dec; 84(23):1833-5. PubMed ID: 1359157
    [No Abstract]   [Full Text] [Related]  

  • 27. Improved Risk Stratification for Breast Cancer Samples Based on the Expression Ratio of the Estrogen and Progesterone Receptor.
    Bendrat K; Fritz P; Müller S; Brockmöller S; Debus A; Friedrichs K; Lindner C; Brinkmann F; Heidemann E; Niendorf A
    Anticancer Res; 2016 Aug; 36(8):3855-63. PubMed ID: 27466487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of gene mutation in ctDNA analysis for hormone receptor-positive metastatic breast cancer.
    Shibayama T; Low SK; Ono M; Kobayashi T; Kobayashi K; Fukada I; Ito Y; Ueno T; Ohno S; Nakamura Y; Takahashi S
    Breast Cancer Res Treat; 2020 Apr; 180(2):331-341. PubMed ID: 32020432
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients.
    Franken A; Honisch E; Reinhardt F; Meier-Stiegen F; Yang L; Jaschinski S; Esposito I; Alberter B; Polzer B; Huebner H; Fasching PA; Pancholi S; Martin LA; Ruckhaeberle E; Schochter F; Tzschaschel M; Hartkopf AD; Mueller V; Niederacher D; Fehm T; Neubauer H
    J Mol Diagn; 2020 Jan; 22(1):111-121. PubMed ID: 31669227
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen Receptor 1 Gene (ESR1) rs2234693 Polymorphism and Breast Cancer Risk in Saudi Women.
    Al-Amri RJ; Alotibi MKH; Al-Raddadi RI; Shebli WTY; Fallatah EIY; Alhujaily AS; Mohamed HS
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3235-3240. PubMed ID: 33247680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ESR1-Amplification-Associated Estrogen Receptor α Activity in Breast Cancer.
    Holst F; Singer CF
    Trends Endocrinol Metab; 2016 Nov; 27(11):751-752. PubMed ID: 27595547
    [No Abstract]   [Full Text] [Related]  

  • 33. Estrogen receptor beta (ERbeta) expression in breast carcinomas is not correlated with estrogen receptor alpha (ERalpha) and prognosis: the Greek experience.
    Stefanou D; Batistatou A; Briasoulis E; Arkoumani E; Agnantis NJ
    Eur J Gynaecol Oncol; 2004; 25(4):457-61. PubMed ID: 15285303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical assay of cellular cycle markers: an alternative to chip-diagnosis of breast cancer].
    Petrov SV; Orlova RV; Raskin GA; Khacanov RSh
    Vopr Onkol; 2007; 53(5):526-30. PubMed ID: 18154114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Biomarkers for Contemporary Therapies in Hormone Receptor-Positive Breast Cancer.
    Freelander A; Brown LJ; Parker A; Segara D; Portman N; Lau B; Lim E
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33671468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene amplification in ductal carcinoma in situ of the breast.
    Burkhardt L; Grob TJ; Hermann I; Burandt E; Choschzick M; Jänicke F; Müller V; Bokemeyer C; Simon R; Sauter G; Wilczak W; Lebeau A
    Breast Cancer Res Treat; 2010 Oct; 123(3):757-65. PubMed ID: 20033484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of Gene Amplification by Multiplex Ligation-Dependent Probe Amplification in Comparison with In Situ Hybridization and Immunohistochemistry.
    Tabarestani S; Ghaderian SM; Rezvani H
    Asian Pac J Cancer Prev; 2015; 16(17):7997-8002. PubMed ID: 26625832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Re: Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.
    Foulkes WD
    J Natl Cancer Inst; 2004 Jul; 96(13):1040-1; author reply 1041. PubMed ID: 15240792
    [No Abstract]   [Full Text] [Related]  

  • 39. The promoter C specific ERalpha isoform is associated with tamoxifen outcome in breast cancer.
    Amaral S; Schroth W; Kugler S; Fritz P; Simon W; Brauch H
    Breast Cancer Res Treat; 2009 Nov; 118(2):323-31. PubMed ID: 19011961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of estrogen receptor alpha variants in breast tumors: implications for predicting response to hormonal therapies.
    Townson SM; O'Connell P
    J Surg Oncol; 2006 Sep; 94(4):271-3. PubMed ID: 16941528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.